MIT has launched an as-yet unnamed spinout to develop a smart drug-delivery pill to help plan more effective treatment regimens for patients.
Massachusetts Institute of Technology (MIT) has launched an as-yet unnamed US-based spinout to commercialise a 3D-printable drug-delivery pill that would enable doctors to more effectively administer medication dosages, R&D Magazine has reported.
The ingestible technology would remain in the patient’s stomach for almost a month, relying on its built-in sensors and wireless Bluetooth transmitters to help professionals judge when medication should be dispersed.
MIT hopes the pill will prevent patients with diseases including HIV and malaria from prematurely…
